Raymond James Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $5

Benzinga Newsdesk www.benzinga.com Positive 70.4%

Neg 0% Neu 0% Pos 70.4%

Raymond James analyst Martin Auster initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price Target of $5.